SCHEMBL13338554

SCHEMBL13338554

CC(C)N(c1ccc(C(C)(C)C)cc1)c1ccc2c3c(cccc13)-c1ccccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
PABPC1 P11940 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 2/20 0.39
CASP3 P42574 2/20 0.39
RAB9A P51151 2/20 0.39
SENP8 Q96LD8 2/20 0.39
SENP7 Q9BQF6 2/20 0.39
SENP6 Q9GZR1 2/20 0.39
PLA2G1B P04054 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
KEAP1 Q14145 3/20 0.35
NFE2L2 Q16236 3/20 0.35
CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13338413 0.86 MAPT (0.45) KDM4EPABPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL13338517 0.85 KDM4E (0.45) KDM4EPABPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL13338690 0.83 MAPT (0.41) KDM4EPABPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL13338368 0.82 MAPT (0.50) KDM4EPABPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL13338809 0.81 KEAP1 (0.42) KDM4EPABPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL13338541 0.81 NR1I2 (0.34) NPC1KEAP1NFE2L2MEN1KMT2A
SCHEMBL13338459 0.80 SIGMAR1 (0.43) KEAP1NFE2L2MEN1KMT2ALMNA
SCHEMBL13338562 0.78 SIGMAR1 (0.39) ALDH1A1L3MBTL1NPC1CASP3RAB9A
SCHEMBL13338456 0.78 CASP1 (0.41) KDM4EPABPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL13338592 0.78 MAPT (0.44) KDM4EPABPC1SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 KDM4E 2780/4885PABPC1 4474/4885SMN1; SMN2 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.